Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.44 |
| ▸ | CA6 | P23280 | 5/20 | 0.44 |
| ▸ | CA7 | P43166 | 5/20 | 0.44 |
| ▸ | CA9 | Q16790 | 5/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.44 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 0.44 |
| ▸ | RECQL | P46063 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 4/20 | 0.42 |
| ▸ | CA4 | P22748 | 4/20 | 0.42 |
| ▸ | CA5A | P35218 | 4/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | CA3 | P07451 | 3/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9437143 | 0.97 | CA12 (0.42) | CA12CA6CA7CA9CA14 | |
| SCHEMBL7262297 | 0.97 | CA12 (0.42) | CA12CA6CA7CA9CA14 | |
| SCHEMBL8874005 | 0.94 | CA12 (0.56) | CA12CA6CA7CA9CA14 | |
| SCHEMBL18217836 | 0.88 | CA12 (0.40) | CA12CA6CA7CA9CA14 | |
| SCHEMBL18217835 | 0.88 | CA12 (0.40) | CA12CA6CA7CA9CA14 | |
| SCHEMBL8015113 | 0.88 | CA12 (0.62) | CA12CA6CA7CA9CA14 | |
| SCHEMBL394823 | 0.87 | TSHR (0.40) | CA12CA6CA7CA9CA14 | |
| SCHEMBL8737489 | 0.87 | CA12 (0.35) | CA12CA6CA7CA9CA14 | |
| SCHEMBL29020509 | 0.87 | TSHR (0.35) | CA12CA6CA7CA9CA14 | |
| SCHEMBL13520206 | 0.85 | TSHR (0.38) | CA12CA6CA7CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11666623-B2 | Tetramaleimide linkers and use thereof | NEWBIO THERAPEUTICS, INC. (CN) | 2023-06-06 | — | — | US | disclosed |
| EP-2646489-B1 | BLOWING CATALYST | HUNTSMAN CORP HUNGARY ZRT (HU) | 2018-07-04 | — | — | EP | disclosed |
| US-RE46374-E1 | Process for preparing di-, tri- and polyamines by homogeneously catalyzed alcohol amination | BASF SE (DE) | 2017-04-25 | — | — | US | disclosed |
| US-9382397-B2 | Blowing catalyst | Huntsman Corporation Hungary ZRt (HU) | 2016-07-05 | — | — | US | disclosed |
| EP-2438038-B1 | PROCESS FOR THE PREPARATION OF SECONDARY OR TERTIARY AMINES | HUNTSMAN CORP HUNGARY ZRT (HU) | 2016-04-20 | — | — | EP | disclosed |
| EP-2683681-B1 | METHOD FOR PRODUCING DIAMINES, TRIAMINES AND POLYAMINES BY HOMOGENEOUSLY CATALYZED ALCOHOL AMINATION | BASF SE (DE) | 2015-07-01 | — | — | EP | disclosed |
| US-8912361-B2 | Process for preparing di-, tri- and polyamines by homogeneously catalyzed alcohol amination | BASF SE (DE) | 2014-12-16 | — | — | US | disclosed |
| US-8853308-B2 | Hydrodispersible polyisocyanate compositions | VENCOREX FRANCE (FR) | 2014-10-07 | — | — | US | disclosed |
| US-8822729-B2 | Method for providing a secondary or tertiary amine | HUNTSMAN INTERNATIONAL LLC (US) | 2014-09-02 | — | — | US | disclosed |
| US-20140155655-A1 | Method for providing a secondary or tertiary amine | Huntsman Corporation Hungary ZRt (HU) | 2014-06-05 | — | — | US | disclosed |
| EP-2438039-B1 | A METHOD FOR SEPARATING N,N-DIALKYLBISAMINOALKYLETHER FROM MIXTURES COMPRISING N,N-DIALKYLBISAMINOALKYLETHER AND AT LEAST ONE OF N,N,N'-TRIALKYLBISAMINOALKYLETHER AND N,N,N',N'-TETRAALKYLBISAMINOALKYLETHER | HUNTSMAN CORP HUNGARY ZRT (HU) | 2013-07-31 | — | — | EP | disclosed |
| WO-2012072441-A1 | BLOWING CATALYST | HUNTSMAN CORPORATION HUNGARY ZRT. (HU) | 2012-06-07 | — | — | WO | disclosed |
| US-20120130132-A1 | METHOD FOR SEPARATING N,N-DIALKYLBISAMINOALKYLETHER FROM MIXTURES COMPRISING N,N-DIALKYLBISAMINOALKYLETHER AND AT LEAST ONE OF N,N,N'-TRIALKYLBISAMINOALKYLETHER AND N,N,N',N'-TETRAALKYLBISAMINOALKYLETHER | HUNTSMAN INTERNATIONAL LLC | 2012-05-24 | — | — | US | disclosed |
| EP-2438038-A1 | A METHOD FOR PROVIDING A SECONDARY OR TERTIARY AMINE | Huntsman Corporation Hungary ZRt. (HU) | 2012-04-11 | — | — | EP | disclosed |
| EP-2438039-A1 | A METHOD FOR SEPARATING N,N-DIALKYLBISAMINOALKYLETHER FROM MIXTURES COMPRISING N,N-DIALKYLBISAMINOALKYLETHER AND AT LEAST ONE OF N,N,N'-TRIALKYLBISAMINOALKYLETHER AND N,N,N',N'-TETRAALKYLBISAMINOALKYLETHER | Huntsman Corporation Hungary ZRt. (HU) | 2012-04-11 | — | — | EP | disclosed |
| US-20120071622-A1 | Method for Providing a Secondary or Tertiary Amine | Huntsman Corporation Hungary ZRt (HU) | 2012-03-22 | — | — | US | disclosed |
| US-20110151127-A1 | NOVEL MIXTURES OF POLYISOCYANATE COMPOSITIONS | PERSTORP FRANCE (FR) | 2011-06-23 | — | — | US | disclosed |
| WO-2010139520-A1 | A Method for Separating N,N-Dialkylbisaminoalkylether from Mixtures Comprising N,N-Dialkylbisaminoalkylether and at least one of N,N,N'-Trialkylbisaminoalkylether and N,N,N',N'-Tetraalkylbisaminoalkylether | HUNTSMAN CORPORATION HUNGARY ZRT. (HU) | 2010-12-09 | — | — | WO | disclosed |
| WO-2010139521-A1 | A METHOD FOR PROVIDING A SECONDARY OR TERTIARY AMINE | HUNTSMAN CORPORATION HUNGARY ZRT. (HU) | 2010-12-09 | — | — | WO | disclosed |
| US-20100273920-A1 | NOVEL HYDRODISPERSIBLE POLYISOCYANATE COMPOSITIONS | PERSTORP FRANCE (FR) | 2010-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120071622-A1 | Method for Providing a Secondary or Tertiary Amine | HRH3, HRH4, NPR3 | CA12 2348/4885CA6 3016/4885CA7 1815/4885 |
| US-20140155655-A1 | Method for providing a secondary or tertiary amine | HRH3, HRH4, GLRA3 | CA12 2557/4885CA6 3160/4885CA7 1953/4885 |
| US-20120130132-A1 | METHOD FOR SEPARATING N,N-DIALKYLBISAMINOALKYLETHER FROM MIXTURES COMPRISING N,N-DIALKYLBISAMINOALKYLETHER AND AT LEAST ONE OF N,N,N'-TRIALKYLBISAMINOALKYLETHER AND N,N,N',N'-TETRAALKYLBISAMINOALKYLETHER | NCLN, NCL, DNPH1 | CA12 2473/4885CA6 3192/4885CA7 1094/4885 |
| US-11666623-B2 | Tetramaleimide linkers and use thereof | MCTS1, CA14, TTL | CA12 11/4885CA6 109/4885CA7 127/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.